Inactive Instrument

Vivoryon Therapeutics AG Stock price Euronext Amsterdam

Equities

DE0007921835

Biotechnology & Medical Research

Sales 2023 * - Sales 2024 * - Capitalization 14.08M 15.17M
Net income 2023 * -23M -24.79M Net income 2024 * -18M -19.4M EV / Sales 2023 * -
Net cash position 2023 * 24.1M 25.97M Net cash position 2024 * 19.55M 21.07M EV / Sales 2024 * -
P/E ratio 2023 *
-0.58 x
P/E ratio 2024 *
-0.75 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 66.82%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 64 11-12-31
Director of Finance/CFO - -
Director/Board Member 56 18-08-30
Members of the board TitleAgeSince
Chairman 74 06-12-31
Director/Board Member 54 06-12-31
Director of Finance/CFO - -
More insiders
Vivoryon Therapeutics N.V. specializes in the research and development of therapeutic products for the treatment of Alzheimer disease. At the end of 2022, the group has a portfolio of a product in phase II clinical development (Varoglutamstat; PQ912) and 2 products in the preclinical development phase.
More about the company
  1. Stock
  2. Equities
  3. Stock Vivoryon Therapeutics N.V.
  4. Stock Vivoryon Therapeutics AG - Euronext Amsterdam